Prevalence and Factors Associated with Adherence to Non-pharmacological Treatment of Hypertensive and Diabetic Patients at Low Complexity Services

Authors

  • Mérida R. Rodríguez-López Pontifical Xavierian University
  • María T. Varela A. Pontifical Xavierian University
  • Hernán Rincón-Hoyos Valle del Lili Foundation
  • Margarita M. Velasco P. Free University
  • Diana M. Caicedo B. University of the Valley
  • Fabián Méndez P. University of the Valley
  • Olga L. Gómez G. University of the Valley

DOI:

https://doi.org/10.17533/udea.rfnsp.v33n2a06

Keywords:

avoidable mortality, eligibility, socioeconomic regions, northern border of Mexico, adherence

Abstract

Objective: to analyze avoidable mortality between 1998 and 2007 in the border states of Northern Mexico to evaluate, indirectly, the quality of the region's health care services. Methodology: the information on mortality provided by the National Health Information System (SINAIS) was analyzed. The unit of analysis was the basic cause of death. The cause was coded in accordance with the ICD-10.Avoidable mortality was classified according to Gomez’s death causes catalog. Likewise, an exploratory analysis was conducted which focused on the relationship between avoidable mortality and eligibility and the socioeconomic level of the municipalities in which the deaths took place. Results: the global rate of avoidable mortality was of 350.2 deaths per 1000 inhabitants in the region. the rates of avoidable mortality by early diagnosis and medical treatment, violence, and HIV/AIDS were 223, 60 and 5 per 1000 inhabitants respectively. These causes of avoidable mortality showed variations between states in terms of magnitude, eligibility and socio-demographic characteristics. Discussion and conclusions: the population living in the states located in the northern border of Mexico have a very intense epidemiological and sociodemographical dynamics. The results of this study suggest that the Mexican health system is being overcome by the high frequency of non-communicable diseases in this region. In social terms, Mexico has structural conditions that facilitate the development of illegal drugs traffic through the Northern states of Mexico. This could be related to the frequency of violent avoidable deaths and, in a subsidiary manner, in HIV/AIDS deaths.
|Abstract
= 1013 veces | PDF (ESPAÑOL (ESPAÑA))
= 396 veces|

Downloads

Download data is not yet available.

Author Biographies

Mérida R. Rodríguez-López, Pontifical Xavierian University

Master in Epidemiology. Health Services Research Group, Comfandi. Professor at the Department of Public Health, Health and Quality of Life Research Group, Pontifical Xavierian University, Cali, Colombia.

María T. Varela A., Pontifical Xavierian University

Psychologist, Master in Epidemiology. Professor at the Pontifical Xavierian University, Cali, Colombia.

Hernán Rincón-Hoyos, Valle del Lili Foundation

Liaison and Interconsulta Psychiatrist, Master in Public Health, Professor. Valle del Lili Foundation and ICESI University, Cali, Colombia.

Margarita M. Velasco P., Free University

General Practitioner, Epidemiology Specialist, Candidate for Master in Epidemiology. Research professor at the Free University, Sectcional Cali, Colombia.

Diana M. Caicedo B., University of the Valley

Surgeon, Master in Epidemiology. Professor at the School of Public Health, Group of Epidemiology and Population Health, University of the Valley, Cali, Colombia.

Fabián Méndez P., University of the Valley

Physician, PhD in Epidemiology. Director and Professor of the School of Public Health, University of the Valley, Cali, Colombia.

Olga L. Gómez G., University of the Valley

Doctor, Master in Public Health. Professor at the School of Public Health, University of the Valley, Cali, Colombia.

References

(1). Organización Mundial de la Salud (OMS). Estadísticas sanitarias mundiales. 2012. [Internet] [Acceso 4/12/2011]. Disponible en: http://www.who.int/gho/publications/world_health_statistics/es_WHS2012_full.pdf.

(2). Ministerio de Protección Social. Encuesta Nacional de Salud. 2007. [Internet] [Acceso 4/12/2011]. Disponible en http://www.scp.com.co/ArchivosSCP/boletines_Pedianet/DocumentosPedia-net/Encuesta_Nacional_de_Salud_2007.pdf.

(3). Fung V, Huang J, Brand R, Newhouse JP, Hsu J. Hypertension treatment in a medicare population: adherence and systolic blood pressure control. Clin Ther 2007; 29 (5): 972-984. DOI: https://doi.org/10.1016/j.clinthera.2007.05.010

(4). Organización Mundial de la Salud. Adherencia a los tratamientos a largo plazo: pruebas para la acción. 2004. [Internet] [Acceso 10/01/2012]. Disponible en: http://www.paho.org/Spanish/AD/DPC/NC/nc-adherencia.htm.

(5). Van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007; 7: 55 DOI: https://doi.org/10.1186/1472-6963-7-55

(6). Martín L. Repercusiones para la salud pública de la adherencia terapéutica deficiente. Rev Cub Sal Púb 2006; 32 (3). Disponible en http://bvs.sld.cu/revistas/spu/vol32_3_06/spu13306.htm

(7). Cramer JA. A systematic review of adherence with medications for diabetes. Diab Care. 2004; 27 (5): 1218-1224. DOI: https://doi.org/10.2337/diacare.27.5.1218

(8). Varela MT. El reto de evaluar la adherencia al tratamiento en la hipertensión arterial. Rev Pens Psic. 2010; 7 (14): 127-140.

(9). Hashmi SK, Afridi MB, Abbas K et al. Factors associated with adherence to anti-hypertensive treatment in Pakistan. PLOS ONE. 2007; 2 (3): e280. DOI: https://doi.org/10.1371/journal.pone.0000280

(10). Warren-Findlow J, Seymour RB. Prevalence rates of hypertension self-care activities among african americans. J Natl Med Assoc. 2011; 103 (6): 503-512. DOI: https://doi.org/10.1016/S0027-9684(15)30365-5

(11). Schmitt KE, Edie CF, Laflam P, Simbartl LA, Thakar CV. Ad-herence to antihypertensive agents and blood pressure control in chronic kidney disease. Am J Nephrol. 2010; 32: 541–548. DOI: https://doi.org/10.1159/000321688

(12). Morgado M, Rolo S, MacedoAF, Pereira L, Castelo-Branco M. Predictors of uncontrolled hypertension and antihypertensive me-dication nonadherence. J Natl Med Assoc. 2010; 1 (4): 196-202. DOI: https://doi.org/10.4103/0975-3583.74263

(13). Broadbent E, Donkin L, Stroh J. Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients. Diab Care. 2011; 34 (2): 338-40. DOI: https://doi.org/10.2337/dc10-1779

(14). Ambaw AD, Alemie GA, Yohannes SM, Mengesha ZB. Adhe-rence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012; 12: 282-288. DOI: https://doi.org/10.1186/1471-2458-12-282

(15). National Kidney Foundation. KDOQI Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007; 49 (2): S12-154. DOI: https://doi.org/10.1053/j.ajkd.2006.12.005

(16). Glasgow RE, Strycker LA, Toobert DJ, Eakin E. A social-ecologic approach to assessing support for disease self-management: the chro-nic illness resources survey. J Behav Med. 2000; 23 (6): 559-83. DOI: https://doi.org/10.1037/t02846-000

(17). Ministerio de la Protección Social de Colombia. Guía para el ma-nejo de la enfermedad renal crónica-ERC. Basado en evidencia. Bogotá: El Ministerio; 2005.

(18). Ribeiro A, Ribeiro S, Dias C et al. Non-pharmacological treatment of hypertension in primary health care: A comparative clinical trial of two education strategies in health and nutrition. BMC Pu-blic Health. 2011; 11:637 DOI: https://doi.org/10.1186/1471-2458-11-637

(19). Tejada T, Fornoni A, Lenz O, Materson BJ. Nonpharmacologic therapy for hypertension: does it really work? Curr Cardiol Rep. 2006; 8 (6): 418-424. DOI: https://doi.org/10.1007/s11886-006-0099-6

(20). Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV et al. Lifestyle interventions to reduce raised blood pres-sure: a systematic review of randomized controlled trials. J Hy-pertens. 2006; 24 (2): 215–233. DOI: https://doi.org/10.1097/01.hjh.0000199800.72563.26

(21). Girotto E, de Andrade SM, Cabrera MA, Matsuo T. Adherence to pharmacological and non pharmacological treatment for arterial hypertension and associated factors in primary care. Cien Saude Colet. 2013; 18 (6): 1763-72. DOI: https://doi.org/10.1590/S1413-81232013000600027

(22). Ohta Y, Tsuchihashi T, Kiyohara K. Relationship between blood pressure control status and lifestyle in hypertensive outpatients. Intern Med. 2011; 50 (19): 2107-2112. DOI: https://doi.org/10.2169/internalmedicine.50.5321

(23). Olivella MC, Bastidas CV, Castiblanco MA. La adherencia al au-tocuidado en personas con enfermedad cardiovascular: abordaje desde el Modelo de Orem. Aquichan. 2012; 12 (1): 53-61. DOI: https://doi.org/10.5294/aqui.2012.12.1.5

(24). Khosravizade Tabasi H, Madarshahian F, Khoshniat Nikoo M et al. Impact of family support improvement behaviors on antidiabe-tic medication adherence and cognition in type 2 diabetic patients. J Diabetes Metab Disord. 2014; 13 (1): 113-119 DOI: https://doi.org/10.1186/s40200-014-0113-2

(25). Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003; 290: 199-206. DOI: https://doi.org/10.1001/jama.290.2.199

(26). Ingaramo RA, Vita N, Bendersky M, Arnolt M et al. Estudio Na-cional Sobre Adherencia al Tratamiento (ENSAT). Rev Fed Arg Cardiol. 2005; 34: 104-111.

(27). Alayón AN, Mosquera-Vásquez, M. Adherencia al tratamiento basado en comportamientos en pacientes diabéticos. Rev Salud Púb. 2008; 10 (5): 777-787. DOI: https://doi.org/10.1590/S0124-00642008000500010

(28). Otero LM, Muñoz A, Figueroa L. Impacto del Modelo Moderador del Riesgo en la Enfermedad Renal Crónica. IPS COMFANDI, Cali, 2006. Col Med. 2007; 38: 274-281.

(29). Rodríguez-López M et al. Strategies to prevent chronic kidney disease progression based on risk assessment in primary care. Primary Care Cardiovascular Journal [Revista en Internet] [Acceso 10/03/2013]. Disponible en: http://www.pccj.eu/images/stories/AheadOfPrint/pccj_rodriguez_std_onlineonly.pdf. doi:10.3132/pccj.2013.046.

(30). Lu CH, Tang ST, Lei YX et al. Community-based interventions in hypertensive patients: a comparison of three health education strategies. BMC Public Health. 2015 Jan 29; 15 (1): 33-46 DOI: https://doi.org/10.1186/s12889-015-1401-6

(31). Lin EH, von Korff M, Ciechanowski P, Peterson D et al. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Ann Fam Med. 2012; 10 (1): 6-14. DOI: https://doi.org/10.1370/afm.1343

Downloads

Published

2015-05-15

How to Cite

1.
Rodríguez-López MR, Varela A. MT, Rincón-Hoyos H, Velasco P. MM, Caicedo B. DM, Méndez P. F, Gómez G. OL. Prevalence and Factors Associated with Adherence to Non-pharmacological Treatment of Hypertensive and Diabetic Patients at Low Complexity Services. Rev. Fac. Nac. Salud Pública [Internet]. 2015 May 15 [cited 2025 Feb. 2];33(2):192-9. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/20065

Issue

Vol. 33 No. 2 (2015)

Section

Research

License

Copyright (c) 2021 Mérida R. Rodríguez-López, María T. Varela A., Hernán Rincón-Hoyos, Margarita M. Velasco P., Diana M. Caicedo B., Fabián Méndez P., Olga L. Gómez G.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The contents of the articles are the responsibility of the authors

The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.

The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.

When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.

Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.

The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.

The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.

The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "

Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)